# FDA EIR - National Cancer Institute, Cancer Therapy Evaluation Program - July 17, 2014

Source: https://www.globalkeysolutions.net/records/eir/national-cancer-institute-cancer-therapy-evaluation-program/0ea41923-e58e-4119-93c8-059ec001ad62

> FDA EIR for National Cancer Institute, Cancer Therapy Evaluation Program on July 17, 2014. Product: Biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: National Cancer Institute, Cancer Therapy Evaluation Program
- Inspection Date: 2014-07-17
- Product Type: Biologics
- Office Name: Center for Drug Evaluation and Research

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/karen-said/01c658cb-f919-414e-bafd-4afc869c6eb3)
- [company_representative](https://www.globalkeysolutions.net/people/l-mary-smith/0a0b6b86-4e5c-477f-b246-bea80e1547a4)
- [company_representative](https://www.globalkeysolutions.net/people/jody-cleveland/0b27e02e-97cc-43f9-9b9d-d0ff9cb1477b)
- [company_representative](https://www.globalkeysolutions.net/people/steven-friedman/0e7e563b-d9ff-495f-8b68-f445a8a54210)
- [company_representative](https://www.globalkeysolutions.net/people/todd-alonzo/11591984-ab05-4297-b985-61e6d1a5207a)

Company: https://www.globalkeysolutions.net/companies/national-cancer-institute-cancer-therapy-evaluation-program/8cc7f4d2-3770-43d0-adba-33439499bb74

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c